NF-κB activity in endothelial cells is modulated by cell substratum interactions and influences chemokine-mediated adhesion of natural killer cells

Cell Transplantation

Volumn 18, Issue 3, 2009, Pages 261-273

  Hess, Shmuel ^a,b   Methe, Heiko ^a,c   Kim, Jong Oh ^c   Edelman, Elazer R ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Endothelial cell; Extracellular matrix; Natural killer cell; NF B

Indexed keywords

CHEMOKINE; COLLAGEN; FRACTALKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYSTYRENE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; IMMUNOGLOBULIN RECEPTOR; MESSENGER RNA;

ANTIGEN RECOGNITION; ARTICLE; CELL ADHESION; CELL INFILTRATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; TISSUE CULTURE; ANIMAL; CELL MEMBRANE; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MONOCYTE; PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT; SWINE; ULTRASTRUCTURE;

ANIMALS; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; CHEMOKINE CX3CL1; CHEMOKINES; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SUS SCROFA;

EID: 67449089804     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909788534979     Document Type: Article

References (35)

1. Aznar-Salatti, J.; Escolar, G.; Cases, A.; Gomez-Ortiz, G.; Anton, P.; Castillo, R.; Revert, L.; Ordinas, A. Uraemic medium causes endothelial cell dysfunction characterized by an alteration of the properties of its subendothelial matrix. Nephrol. Dial. Transplant. 10(12):2199-2204; 1995.
2. Berahovich, R. D.; Lai, N. L.; Wei, Z.; Lanier, L. L.; Schall, T. J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 177(11):7833-7840; 2006.
3. Borlongan, C. V.; Thanos, C. G.; Skinner, S. J.; Geaney, M.; Emerich, D. F. Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease. Cell Transplant. 16(10):987-992; 2007.
4. Boudreau, N.; Werb, Z.; Bissell, M. J. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA 93(8):3509-3513; 1996.
5. Cao, G.; Lu, Y.; Gao, R.; Xin, Y.; Teng, D.; Wang, J.; Li, Y. Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection. Transplant. Proc. 38(7):1998-2000; 2006.
6. Cines, D. B.; Pollak, E. S.; Buck, C. A.; Loscalzo, J.; Zimmerman, G. A.; McEver, R. P.; Pober, J. S.; Wick, T. M.; Konkle, B. A.; Schwartz, B. S.; Barnathan, E. S.; McCrae, K. R.; Hug, B. A.; Schmidt, A. M.; Stern, D. M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91(10):3527-3561; 1998.
7. Cybulsky, M. I.; Hegele, R. A. The fractalkine receptor CX3CR1 is a key mediator of atherogenesis. J. Clin. Invest. 111(8):1118-1120; 2003.
8. Davidson, A.; Diamond, B. Autoimmune diseases. N. Engl. J. Med. 345(5):340-350; 2001.
9. Ghosh, S.; Karin, M. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl.):S81-96; 2002.
10. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352(16):1685-1695; 2005.
11. Haskell, C. A.; Hancock, W. W.; Salant, D. J.; Gao, W.; Csizmadia, V.; Peters, W.; Faia, K.; Fituri, O.; Rottman, J. B.; Charo, I. F. Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J. Clin. Invest. 108(5):679-688; 2001.
12. Kempe, S.; Kestler, H.; Lasar, A.; Wirth, T. NF-kappaB controls the global pro-inflammatory response in endothelial cells: Evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res. 33(16):5308-5319; 2005. (Pubitemid 41487834)
13. Kishore, N.; Sommers, C.; Mathialagan, S.; Guzova, J.; Yao, M.; Hauser, S.; Huynh, K.; Bonar, S.; Mielke, C.; Albee, L.; Weier, R.; Graneto, M.; Hanau, C.; Perry, T.; Tripp, C. S. A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J. Biol. Chem. 278(35):32861-32871; 2003.
14. Liu, P.; Patil, S.; Rojas, M.; Fong, A. M.; Smyth, S. S.; Patel, D. D. CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. Arterioscler. Thromb. Vasc. Biol. 26(9):2056-2062; 2006.
15. Liu, P.; Yu, Y. R.; Spencer, J. A.; Johnson, A. E.; Vallanat, C. T.; Fong, A. M.; Patterson, C.; Patel, D. D. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 28(2):243-250; 2008.
16. Lukashev, M. E.; Werb, Z. ECM signalling: Orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 8(11):437-441; 1998. (Pubitemid 28529716)
17. Methe, H.; Edelman, E. R. Cell-matrix contact prevents recognition and damage of endothelial cells in states of heightened immunity. Circulation 114(1 Suppl.):I233-238; 2006.
18. Methe, H.; Groothuis, A.; Sayegh, M. H.; Edelman, E. R. Matrix adherence of endothelial cells attenuates immune reactivity: Induction of hyporesponsiveness in allo- and xenogeneic models. FASEB J. 21(7):1515-1526; 2007.
19. Methe, H.; Hess, S.; Edelman, E. R. Endothelial cell-matrix interactions determine maturation of dendritic cells. Eur. J. Immunol. 37(7):1773-1784; 2007.
20. Methe, H.; Hess, S.; Edelman, E. R. Endothelial immunogenicity - a matter of matrix microarchitecture. Thromb. Haemost. 98(2):278-282; 2007.
21. Methe, H.; Nugent, H. M.; Groothuis, A.; Seifert, P.; Sayegh, M. H.; Edelman, E. R. Matrix embedding alters the immune response against endothelial cells in vitro and in vivo. Circulation 112(9 Suppl.):I89-95; 2005.
22. Nathan, A.; Nugent, M. A.; Edelman, E. R. Tissue engineered perivascular endothelial cell implants regulate vascular injury. Proc. Natl. Acad. Sci. USA 92(18):8130-8134; 1995.
23. Navarro-Alvarez, N.; Rivas-Carrillo, J. D.; Soto-Gutierrez, A.; Yuasa, T.; Okitsu, T.; Noguchi, H.; Matsumoto, S.; Takei, J.; Tanaka, N.; Kobayashi, N. Reestablishment of microenvironment is necessary to maintain in vitro and in vivo human islet function. Cell Transplant. 17(1-2):111-119; 2008. (Pubitemid 351551386)
24. Nugent, H. M.; Edelman, E. R. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. J. Surg. Res. 99(2):228-234; 2001.
25. Nugent, H. M.; Rogers, C.; Edelman, E. R. Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ. Res. 84(4):384-391; 1999.
26. Obara, H.; Nagasaki, K.; Hsieh, C. L.; Ogura, Y.; Esquivel, C. O.; Martinez, O. M.; Krams, S. M. IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am. J. Transplant. 5(9):2094-2103; 2005.
27. Okruhlicova, L.; Tribulova, N.; Weismann, P.; Sotnikova, R. Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell Res. 15(7):532-538; 2005.
28. Orr, A. W.; Sanders, J. M.; Bevard, M.; Coleman, E.; Sarembock, I. J.; Schwartz, M. A. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: A potential role in atherosclerosis. J. Cell Biol. 169(1):191-202; 2005.
29. Pober, J. S.; Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7(10):803-815; 2007.
30. Robertson, M. J. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71(2):173-183; 2002.
31. Robinson, L. A.; Nataraj, C.; Thomas, D. W.; Cosby, J. M.; Griffiths, R.; Bautch, V. L.; Patel, D. D.; Coffman, T. M. The chemokine CX3CL1 regulates NK cell activity in vivo. Cell Immunol. 225(2):122-130; 2003.
32. Umehara, H.; Imai, T. Role of fractalkine in leukocyte adhesion and migration and in vascular injury. Drug News Perspect. 14(8):460-464; 2001. (Pubitemid 34130742)
33. Vogl-Willis, C. A.; Edwards, I. J. High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells. Biochim. Biophys. Acta 1672(1):36-45; 2004.
34. Witko-Sarsat, V.; Rieu, P.; Descamps-Latscha, B.; Lesavre, P.; Halbwachs-Mecarelli, L. Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest. 80(5):617-653; 2000.
35. Yoneda, O.; Imai, T.; Goda, S.; Inoue, H.; Yamauchi, A.; Okazaki, T.; Imai, H.; Yoshie, O.; Bloom, E. T.; Domae, N.; Umehara, H. Fractalkine-mediated endothelial cell injury by NK cells. J. Immunol. 164(8):4055-4062; 2000. (Pubitemid 30215060)